Why Compugen Stock Crumbled Today | The Motley Fool
Investors indicated their displeasure with the company's recent fundamentals.
Source: fool.com
Page 27 - Compugen News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Compugen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Compugen Today - Breaking & Trending Today
Compugen Reports Third Quarter 2022 Results
New encouraging preliminary clinical data, presented at SITC 2022, showing anti-tumor activity supported by potent immune activation in the tumor...
Source: prnewswire.com
Compugen to Participate in the Stifel Healthcare Conference
/PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, announced today...
Source: prnewswire.com
Compugen's COM701 (anti-PVRIG) in Combination with Nivolumab Demonstrates Preliminary Anti-Tumor Activity and Potent Immune Activation in Metastatic MSS-CRC Patients
COM701 in combination with nivolumab demonstrated encouraging 12% ORR in 3L+ MSS-CRC patients with liver metastases, compared to 0% ORR historically for other...
Source: prnewswire.com
Compugen Announces Receipt of Nasdaq Delisting Notice
/PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, announced today...
Source: prnewswire.com